A Pilot Comparative Study of the Genomic Molecular and Clinical Profiles of Patients With Lung Cancer, COPD, or Asthma Treated With Symbicort Turbuhaler.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions; Biomarker; Pharmacogenomic; Therapeutic Use
- 24 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Dec 2007 New trial record.